TfR-1-IN-1
Based on 1 publication(s) in Google Scholar
TfR-1-IN-1 is a transferrin receptor-1 (TfR-1) inhibitor with tumor cell-specific activity. TfR-1-IN-1 reduces TfR-1 expression, impairs mitochondrial function, induces cell apoptosis, necroptosis and ferroptosis, and increases intracellular iron (II) levels. TfR-1-IN-1 decreases the metabolic activity of cancer cells. TfR-1-IN-1 can be used for the research of ovarian cancer, breast cancer and acute myeloid leukemia.
For research use only. We do not sell to patients.
- Purity : 96.96%
- CAS No.: 1643444-62-5
- Formula: C20H12ClF2FeN2O2
- Molecular Weight:441.62
-
Storage:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
Publications Citing Use of MedChemExpress (MCE) TfR-1-IN-1
More
Biological Activity
Description
IC50 & Target
[1]|
TfR-1 |
In Vitro
TfR-1-IN-1 (C4) (0.1-10 μM; 72 h) potently reduces the metabolic activity of MDA-MB 231, HL-60 and A2780cis tumor cells, with IC50 values of 0.46, 0.48 and 0.51 μM, respectively; it also exhibits tumor cell specificity at a concentration of 0.5 μM and shows no effect on non-malignant HS-5 cells[1].
TfR-1-IN-1 (1 μM; 2-24 h) increases intracellular iron levels in MDA-MB 231 cells, with the level rising from 69.7 pg Fe/μg protein at 12 h to 86.0 pg Fe/μg protein at 24 h[1].
TfR-1-IN-1 (0.1-1 μM; 12-24 h) downregulates TfR-1 expression in MDA-MB 231 cells in a concentration- and time-dependent manner[1].
TfR-1-IN-1 (1 μM; 4-20 h) significantly increases the labile iron 2+ pool in MDA-MB 231 cells within 4 h, while ferristatin II-mediated inhibition of TfR-1 partially attenuates this effect[1].
TfR-1-IN-1 (0.1-0.5 μM; 24 h) reduces the mitochondrial membrane potential of MDA-MB 231 cells in a concentration-dependent manner, and treatment with 0.5 μM for 24 h decreases ΔΨm to 57.3% of that in the control group[1].
TfR-1-IN-1 (1 μM; 24 h) induces cell death in MDA-MB 231 cells, with apoptotic death accounting for 25.9% and non-apoptotic death accounting for 49.8%[1].
TfR-1-IN-1 (0.1-1 μM; 2-4 h) induces concentration-dependent lipid peroxidation in MDA-MB 231 cells, with a peroxidation level of 3.5% observed after treatment with 1 μM for 4 h, whereas non-malignant HS-5 cells show only an extremely weak response[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:MDA-MB 231, HL-60, and A2780cis tumor cells, HS-5 cells
-
Concentration:0.1, 0.25, 0.5, 1, 10 μM
-
Incubation Time:72 h
-
Result:Reduced metabolic activity in a concentration-dependent manner across all tumor cell lines.
Reduced metabolic activity in MDA-MB 231 cells with an IC50 of 0.46 μM.
Reduced metabolic activity in HL-60 cells with an IC50 of 0.48 μM.
Reduced metabolic activity in A2780cis cells with an IC50 of 0.51 μM.
Reduced metabolic activity in A2780 cells with an IC50 of 1.79 μM.
Showed no reduction in metabolic activity in HS-5 cells at 0.5 μM.
Inhibited HS-5 cell metabolic activity to 56.2% at 1 μM.
Reduced HS-5 cell metabolic activity to <10% at 10 μM.
-
Cell Line:MDA-MB 231 breast cancer cells
-
Concentration:0.1 μM, 1 μM
-
Incubation Time:12, 24 h
-
Result:Reduced TfR-1 expression to 69.2% of untreated cells at 0.1 μM after 12 h.
Reduced TfR-1 expression to 38.4% of untreated cells at 0.1 μM after 24 h.
Reduced TfR-1 expression to 51.8% of untreated cells at 1 μM after 12 h.
Reduced TfR-1 expression to 33.7% of untreated cells at 1 μM after 24 h.
Exerted a greater 12 h effect on TfR-1 expression than 1 μM FeCl3 (61.1% expression).
-
Cell Line:MDA-MB 231 breast cancer cells
-
Concentration:1 μM
-
Incubation Time:24 h
-
Result:Increased apoptotic cell death to 25.9% compared to untreated cells (13.5% apoptotic).
Increased nonapoptotic cell death to 49.8% compared to untreated cells (15.9% nonapoptotic dead cells).
Chemical Information
-
CAS No. 1643444-62-5
-
Appearance Solid
-
Molecular Weight 441.62
-
Formula C20H12ClF2FeN2O2
-
Color Brown to black
-
SMILES
FC1=CC=CC2=C1C=[N]3C4=CC=CC=C4[N]5=CC6=C(F)C=CC=C6[O-][Fe+3]5([Cl-])3[O-]2
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Publications (1)
-
Journal Impact Factor
-
Most Recent
-
Environ Sci Technol
Iron-Rich Particles Drive Pulmonary Toxicity of Coal Combustion-Derived Fine Particles via Transferrin Receptor-Mediated Ferroptosis. [Abstract]2026 Mar 17;60(10):7716-7732. PMID: 41766572
Solvent & Solubility
In Vitro:
DMSO : 20 mg/mL (45.29 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Protocols
-
RNA extraction experimental
By lysing cells, releasing RNA, and removing impurities such as proteins and DNA, high-purity RNA products are finally obtained. The commonly used traditional method is the guanidine isothiocyanate/phenol/chloroform method (Trizol), which is suitable for a variety of animal materials including animal tissues, microorganisms, cultured cells, etc., and most plant materials.
-
Mitochondrial membrane-potential fluorescent assay
Mitochondrial membrane potential fluorescent assays estimate ΔΨm in living cells using lipophilic cationic dyes such as TMRM, TMRE, rhodamine 123, and JC-1, which accumulate in mitochondria according to membrane polarization; loss of signal after FCCP or CCCP treatment is interpreted as mitochondrial depolarization. TMRM/TMRE and rhodamine 123 are commonly used for semi-quantitative live-cell microscopy or flow cytometry, while JC-1 can report a shift from red aggregate fluorescence to green monomer fluorescence during depolarization; interpretation requires controls because dye concentration, quenching mode, cell type, dye efflux, and mitochondrial mass can affect fluorescence independently of ΔΨm.
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Mitochondrial membrane-potential and mitochondrial mass staining
Mitochondrial membrane potential staining measures the electrochemical polarization across the mitochondrial inner membrane in live cells using lipophilic cationic fluorescent probes; early rhodamine-based work showed that selective mitochondrial dye accumulation is lost when the mitochondrial transmembrane potential is dissipated. JC-1 reports mitochondrial polarization by shifting from green monomer fluorescence to red J-aggregate fluorescence as dye concentration increases within energized mitochondria; therefore, the red/green fluorescence ratio is used as a relative readout of mitochondrial membrane potential. TMRE or TMRM staining provides a single-channel relative readout because these cationic rhodamine esters accumulate in polarized mitochondria, and lower fluorescence indicates reduced mitochondrial polarization when acquisition and dye-loading conditions are controlled. Mitochondrial mass staining is commonly performed with MitoTracker Green FM or related MitoTracker dyes as
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Ferroptosis Solutions
Ferroptosis is an iron-dependent, non-apoptotic form of regulated cell death characterized by lethal lipid peroxidation and sensitivity to suppression by iron chelators or lipophilic radical-trapping antioxidants. The core pathway links cystine uptake through system Xc−, glutathione availability, GPX4-dependent detoxification of phospholipid hydroperoxides, iron-dependent oxidative reactions, and polyunsaturated-phospholipid metabolism into a cell-death program that is biochemically and morphologically distinct from apoptosis, necrosis, and autophagy. The ferroptosis pathway is experimentally linked to phenotype through chemical and genetic perturbation. Erastin induces ferroptosis by inhibiting cystine uptake through system Xc− and weakening antioxidant defenses, while GPX4 inhibition or depletion causes lipid peroxide accumulation and ferroptotic cancer-cell death. ACSL4 and oxidizable arachidonoyl- or adrenoyl-containing phosphatidylethanolamines shape ferroptosis sensitivity by con
-
MTT Cell Proliferation Assay
The MTT assay is a colorimetric endpoint assay for estimating viable cell number, cell growth, cytotoxicity, or cell activation in cultured mammalian cells. Living cells reduce the yellow tetrazolium salt MTT into purple/blue formazan, while dead cells do not generate the same signal; the resulting color can be quantified with a multiwell spectrophotometer. MTT reduction is commonly interpreted as a readout of metabolic activity that often correlates with viable cell number, but it should not be treated as a direct cell-counting method unless the assay is optimized for the cell type and experimental condition. Studies show that MTT reduction can involve mitochondrial and non-mitochondrial reducing systems, and formazan may accumulate in intracellular lipid droplets rather than simply marking mitochondria.
-
Breast Cancer Modeling
Breast cancer is a heterogeneous cancer, and it has been distinguished into four subtypes: luminal A, luminal B, HER2-positive and basal-like. Molecular mutations, epigenetic alterations, hormone exposure and immune microenvironment are related to the progression of breast cancer.
Purity & Documentation
-
Data Sheet (290 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Handling Instructions (2659 KB)
References
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 2.2644 mL | 11.3220 mL | 22.6439 mL | 56.6098 mL |
| 5 mM | 0.4529 mL | 2.2644 mL | 4.5288 mL | 11.3220 mL | |
| 10 mM | 0.2264 mL | 1.1322 mL | 2.2644 mL | 5.6610 mL | |
| 15 mM | 0.1510 mL | 0.7548 mL | 1.5096 mL | 3.7740 mL | |
| 20 mM | 0.1132 mL | 0.5661 mL | 1.1322 mL | 2.8305 mL | |
| 25 mM | 0.0906 mL | 0.4529 mL | 0.9058 mL | 2.2644 mL | |
| 30 mM | 0.0755 mL | 0.3774 mL | 0.7548 mL | 1.8870 mL | |
| 40 mM | 0.0566 mL | 0.2830 mL | 0.5661 mL | 1.4152 mL |